Cancer Research UK, Cancer Research Technology and HitGen Ltd have entered into a licence agreement to develop a novel class of drugs in lung cancer.
A one-off bowel screening test reduces the risk of developing bowel cancer by more than one third and could save thousands of lives.
People who are overweight in their twenties and become obese later in life may be three times more likely to develop oesophageal or upper stomach cancer.
A new Cancer Research UK report reveals that GPs want more support when offering drugs that lower the risk of certain cancers.
Cancer Research UK announces that four international teams are the first recipients of its global Grand Challenge competition.